Health Care & Life Sciences » Pharmaceuticals | Samil Pharmaceutical Co. Ltd.

Samil Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,930
11,190
588
887
1,267
8,563
Depreciation, Depletion & Amortization
3,528
3,412
3,039
3,147
3,643
3,686
Other Funds
-
100
100
-
-
3,747
Funds from Operations
2,469
9,016
6,795
8,432
5,166
1,130
Changes in Working Capital
5,249
3,872
4,655
3,614
4,251
3,736
Net Operating Cash Flow
2,780
12,888
2,140
4,818
915
4,866
Capital Expenditures
1,882
5,784
2,536
4,453
36,331
Sale of Fixed Assets & Businesses
49
53
623
532
32
Purchase/Sale of Investments
19,257
12,446
8,759
1,003
1,093
Net Investing Cash Flow
17,643
18,022
9,107
3,153
36,325
Cash Dividends Paid - Total
782
782
1,021
1,021
766
Issuance/Reduction of Debt, Net
4,000
10,200
8,000
2,000
31,000
Net Financing Cash Flow
4,782
8,831
9,121
979
30,234
Net Change in Cash
9,969
22,079
2,126
2,757
5,176
Free Cash Flow
4,619
18,180
217
749
35,249
Other Sources
302
155
2,261
320
2,016
Change in Capital Stock
-
687
-
-
-
Exchange Rate Effect
112
-
-
112
-
Other Uses
83
-
-
555
949

About Samil Pharmaceutical Co.

View Profile
Address
155 Hyoryeong-ro
Seoul SL 06666
Korea, Republic Of
Employees -
Website http://www.samil-pharm.com
Updated 07/08/2019
Samil Pharmaceutical Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include CNS Drugs, Ophthalmic Drugs, Respiratory Drugs, Genito-urinary Drugs, Antibiotics Chemotherapeutics, Circulatory Drugs, Gastro-Intestinal Drugs, Agents for Diabetes Mellitus, Hormones, Metabolic Drugs, Disinfectants, Amino Acids, Dental Preparations, Antipyretic, Allergy Drugs, Antihistamines, Analgesic and Anti-inflammatory Agents. The company was founded on October 7, 1947 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.